Behavioral Treatment of Obesity: Its application to type II diabetes

Diabetes Care ◽  
1993 ◽  
Vol 16 (1) ◽  
pp. 193-199 ◽  
Author(s):  
R. R. Wing
2021 ◽  
Author(s):  
Weimin Lin ◽  
Xianyu Wen ◽  
Xuexin Li ◽  
Lei Chen ◽  
Wei Wei ◽  
...  

Excessive adipogenesis caused obesity, which was a serious risk of health and led to a series of diseases, including type II diabetes (T2D) for example. Adipocyte as the basic unit of adipose tissue has emerged as one of significant target of the treatment of obesity-related metabolic syndromes by revealed its adipogenic molecular mechanism. MicroRNAs (miRNAs) have been demonstrated involving adipogenesis, and played a crucial role in the competitive endogenous RNA (ceRNA) effect. Besides that, C/EBPα as a crucial adipogenic regulator still lacked epigenetic explanation during pre-adipocyte adipogenesis. In this study, we first verified FoxO1 was one of the ceRNA of C/EBPα. They co-regulated adipogenesis through formed a protein complex that directly bound to its promoter to activate AdipoQ, and AdipoQ (Adiponectin) was a negative adipocytokines that suppressed adipogenesis, which played an important role in retaining adipogensis balance. Moreover, an adipose tissue specific enriched miRNA, miR-144 was the key regulator of the ceRNA effect between C/EBPα and FoxO1, which mediated the C/EBPα-FoxO1 complex formation, thus altered AdipoQ, furthermore regulated pre-adipocyte adipogenesis. This research will provide a new supplementary idea of the C/EBPα epigenetic role in pre-adipocyte adipogenesis.


2001 ◽  
Vol 2 (2) ◽  
pp. 133-140 ◽  
Author(s):  
Drew A. Anderson ◽  
Jennifer R. Shapiro ◽  
Jennifer D. Lundgren

Sign in / Sign up

Export Citation Format

Share Document